Showing results (101-110 of 185) with videos related to
Sort By:
Pageof 19
Endoscopy|January 26, 2016
Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopistsStephan R Vavricka, Michael C Sulz, Lukas Degen, et al.United European Gastroenterology Journal|August 25, 2021
The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patientsRené Roth, Stephan Vavricka, Michael Scharl, et al.The American Journal of Gastroenterology|October 19, 2018
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort StudySylvie Scharl, Christiane Barthel, Jean-Benoit Rossel, et al.Plos One|September 1, 2012
Fc gamma receptor CD64 modulates the inhibitory activity of infliximabKacper A Wojtal, Gerhard Rogler, Michael Scharl, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2019
Association of Alterations in Intestinal Microbiota With Impaired Psychological Function in Patients With Inflammatory Bowel Diseases in RemissionFabienne Humbel, Jessica Harrell Rieder, Yannick Franc, et al.Plos One|July 29, 2016
Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD CohortMarianne R Spalinger, Jonas Zeitz, Luc Biedermann, et al.Inflammatory Intestinal Diseases|June 21, 2018
Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease CohortJonas Zeitz, Nicolas Fournier, Christian Labenz, et al.Journal of Crohn'S & Colitis|April 5, 2018
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort StudyLevente Parragi, N Fournier, Jonas Zeitz, et al.Alimentary Pharmacology & Therapeutics|October 31, 2018
Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomesEkaterina Safroneeva, Lukas Balsiger, David Hafner, et al.Plos One|April 26, 2019
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort studyLorenz Bon, Sylvie Scharl, Stephan Vavricka, et al.Pageof 19